A64 - Unspecified sexually transmitted disease | ICD-10-CM.
For claims for screening for syphilis in pregnant women at increased risk for STIs use the following ICD-10-CM diagnosis codes: • Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission; • and any of: Z72.
3 - Encounter for screening for infections with a predominantly sexual mode of transmission.
2 - Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission.
This policy describes reimbursement for Infectious agent detection by nucleic acid (DNA or RNA) assays for the detection of Sexually Transmitted Infections (STI), represented by CPT codes 87491, 87591, 87661, or 87801, and submitted for reimbursement on professional and facility claim forms.
ICD-10 Code for Other problems related to lifestyle- Z72. 89- Codify by AAPC. Factors influencing health status and contact with health services.
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Instructions under Z01. 411 and Z01. 419 (routine gynecological exam with or without abnormal findings) indicate that the codes include a cervical Pap screening and instruct us to add additional codes for HPV screening and/or a vaginal Pap test.
Chlamydial infection of genitourinary tract, unspecified A56. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM A56. 2 became effective on October 1, 2021.
ICD-10 code A69. 2 for Lyme disease is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
2022 ICD-10-CM Diagnosis Code Z11. 59: Encounter for screening for other viral diseases.
The Current Procedural Terminology (CPT®) code 87491 as maintained by American Medical Association, is a medical procedural code under the range - Infectious Agent Antigen Detection.
Z12. 11: Encounter for screening for malignant neoplasm of the colon.